Apollo Hospitals to take Tata Medical's Covid test kit across country

Tata to make one million kits a year initially at Chennai unit, Apollo to tap Delhi market in December

Apollo Hospitals Group and Tata Medical and Diagnostics (Tata MD), the new healthcare venture of the Tata group, today announced a collaboration to launch TataMD CHECK, the world’s first CRISPR Cas-9 based diagnostic test, across the country.

Both the companies have entered into “commercial partnership”. The financial terms of the tie-up were not disclosed.

Indigenously developed kits will be manufactured at TataMD's facility at Sriperumbudr near Chennai. Initial production capacity is one million units per annum.

Girish Krishnamurthy, CEO & MD, Tata Medical and Diagnostics refused to share investment figures and financials on the commercial agreement.

Sangita Reddy, Joint Managing